Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities
Sébastien Morin, Giulia Segafredo, Manuele Piccolis, et al.
The Lancet Global Health (2022) Vol. 11, Iss. 1, pp. e145-e154
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Sequence modeling and design from molecular to genome scale with Evo
Éric Nguyen, Michael Poli, Matthew G. Durrant, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 52
Sequence modeling and design from molecular to genome scale with Evo
Eric Nguyen, Michael Poli, Matthew G. Durrant, et al.
Science (2024) Vol. 386, Iss. 6723
Open Access | Times Cited: 42
The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs
Andrew Farlow, Els Torreele, Glenda Gray, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 690-690
Open Access | Times Cited: 32
Global inequity in pediatric and congenital heart care—is it economics or inertia?
Bistra Zheleva
Indian Journal of Thoracic and Cardiovascular Surgery (2025)
Closed Access
Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider’s story
Charles Gore, Sébastien Morin, John‐Arne Røttingen, et al.
BMJ Global Health (2023) Vol. 8, Iss. 9, pp. e012964-e012964
Open Access | Times Cited: 14
Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs—reducing global inequity
Heather J. Zar, Manuele Piccolis, Jonne Terstappen, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 10, pp. e1582-e1583
Open Access | Times Cited: 4
Impact of Excipient Extraction and Buffer Exchange on Recombinant Monoclonal Antibody Stability
Deepika Sarin, Kunal Krishna, M. Reza Nejadnik, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1872-1883
Open Access | Times Cited: 3
Geographical and sociodemographic epidemiology of inflammatory bowel disease in young females from 2010 to 2019
Pojsakorn Danpanichkul, Kwanjit Duangsonk, Chawin Lopimpisuth, et al.
Digestive and Liver Disease (2024)
Closed Access | Times Cited: 3
The economics of biosimilars and challenges to biosimilar adoption in low- and middle-income countries
Matthias Calamia, Ivo Abraham
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 8, pp. 653-657
Closed Access | Times Cited: 5
Trastuzumab‐based nanomedicines for breast cancer therapy: Recent advances and future opportunities
Cyril Tlou Selepe, Khanyisile Sheer Dhlamini, Lesego Tshweu, et al.
Nano Select (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 1
Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries
Shelly Malhotra, A.G.W. Cameron, Dzintars Gotham, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 7, pp. e0003418-e0003418
Open Access | Times Cited: 1
Intravenous Immunoglobulin G (IVIG) Need Assessment Survey Toward Local Manufacturing of IVIG Using a Mini-Pool Plasma Fractionation Technique
Bisrat Bekele, Zekarias Masresha, Mekdelawit Alemayehu, et al.
Health Services Insights (2023) Vol. 16
Open Access | Times Cited: 4
Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond
Lisa Gieber, Vincent Muturi‐Kioi, Shelly Malhotra, et al.
Pharmaceutical Medicine (2023) Vol. 37, Iss. 3, pp. 203-214
Open Access | Times Cited: 4
Voluntary licensing of long‐acting HIV prevention and treatment regimens: using a proven collaboration‐ and competition‐based mechanism to rapidly expand at‐scale, sustainable, quality‐assured and affordable supplies in LMICs
Lobna Gaayeb, Aditi Das, Ike James, et al.
Journal of the International AIDS Society (2023) Vol. 26, Iss. S2
Open Access | Times Cited: 4
Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries
Hyunjung Woo, Gyeongseon Shin, Donghwan Lee, et al.
BioDrugs (2023) Vol. 38, Iss. 1, pp. 133-144
Open Access | Times Cited: 4
Global outlook on affordability of biotherapeutic drugs
Anurag S. Rathore, Peter J. Gardner, Hemlata Chhabra, et al.
Annals of the New York Academy of Sciences (2024) Vol. 1537, Iss. 1, pp. 168-178
Closed Access | Times Cited: 1
Fármacos Anticorpos Monoclonais para o Tratamento do Câncer: uma Perspectiva Brasileira
Júlia Teixeira de Menezes, Maria Carolina Theisen, Vanessa da Costa Flores, et al.
Revista Brasileira de Cancerologia (2024) Vol. 70, Iss. 1
Open Access
Monoclonal antibody biosimilars for cancer treatment
Linda N. Broer, Daan G. Knapen, Derk‐Jan A. de Groot, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 110115-110115
Open Access
STREAMLINING REGULATORY PROCEDURE FOR ACCELERATING MEDICAL PRODUCT ASSESSMENT IN FRANCE, GERMANY, AND THE UK

International Journal of Biology Pharmacy and Allied Sciences (2024) Vol. 13, Iss. 8
Open Access
Immunotherapy of Lung Cancer in Countries with Limited Resources; Current Challenges and Potential Solutions
Arefeh Saeedian, Asghar Kazemzadeh, Seyed Alireza Javadinia
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 8, pp. 2583-2584
Open Access
Advancing Therapeutic and Vaccine Proteins: Switching from Recombinant to Ribosomal Delivery—A Humanitarian Cause
Sarfaraz K. Niazi, Matthias Magoola
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12797-12797
Open Access
The Role of Pharmacometrics in Advancing the Therapies for Autoimmune Diseases
Artur Świerczek, Dominika Batko, Elżbieta Wyska
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1559-1559
Open Access
The Global, Regional, and National Patterns of Change in the Burden of Lymphoma, 1990-2021: An Analysis of the Global Burden of Disease Study 2021 and Forecast to 2035
Hongjiang Pu, Mengling Liu, Yen‐Fu Chen, et al.
(2024)
Closed Access
Informed consent and risk communication challenges in antimicrobial clinical trials: a scoping review
Yiyun Shou, Jie Ming Yeo, Alexander Shao‐Rong Pang, et al.
BMJ Open (2024) Vol. 14, Iss. 11, pp. e082096-e082096
Open Access
Antibodies for HIV prevention: the path forward
Shelly Malhotra, Rachel Baggaley, Sharonann Lynch, et al.
Journal of the International AIDS Society (2023) Vol. 26, Iss. 5
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top